Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Cushing's Syndrome: A Historic Review of the Treatment Strategies and Corresponding Outcomes in a Single Tertiary Center over the Past Half-Century.

Nankova A, Yaneva M, Elenkova A, Tcharaktchiev D, Marinov M, Hadzhiyanev A, Sechanov T, Gantchev G, Todorov G, Kirilov G, Kalinov K, Andreeva M, Zacharieva S.

Horm Metab Res. 2018 Apr;50(4):280-289. doi: 10.1055/a-0580-0460. Epub 2018 Apr 5.

PMID:
29621813
2.

Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYN.

Valassi E, Feelders R, Maiter D, Chanson P, Yaneva M, Reincke M, Krsek M, Tóth M, Webb SM, Santos A, Paiva I, Komerdus I, Droste M, Tabarin A, Strasburger CJ, Franz H, Trainer PJ, Newell-Price J, Wass JA, Papakokkinou E, Ragnarsson O; ERCUSYN Study Group.

Clin Endocrinol (Oxf). 2018 Jun;88(6):787-798. doi: 10.1111/cen.13600. Epub 2018 Apr 16. Erratum in: Clin Endocrinol (Oxf). 2018 Nov;89(5):678.

PMID:
29574994
3.

Multiple Myeloma with Advanced Bone Disease and Low Tumor Burden - Different Clinical Presentation but Similar Outcome after Bortezomib-Based Therapy and Radiotherapy.

Goranova-Marinova V, Yaneva M, Deneva T, Goranov S, Mužina Mišić D.

Acta Clin Croat. 2017 Jun;56(2):262-269. doi: 10.20471/acc.2017.56.02.09.

PMID:
29485793
4.

Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN.

Valassi E, Franz H, Brue T, Feelders RA, Netea-Maier R, Tsagarakis S, Webb SM, Yaneva M, Reincke M, Droste M, Komerdus I, Maiter D, Kastelan D, Chanson P, Pfeifer M, Strasburger CJ, Tóth M, Chabre O, Krsek M, Fajardo C, Bolanowski M, Santos A, Trainer PJ, Wass JAH, Tabarin A; ERCUSYN Study Group.

Eur J Endocrinol. 2018 Apr;178(4):399-409. doi: 10.1530/EJE-17-0997. Epub 2018 Feb 12.

PMID:
29440375
5.

Nuclear Medicine Methods for Evaluation of Abnormal Parathyroid Glands in Patients with Primary and Secondary Hyperparathyroidism.

Botushanova AD, Botushanov NP, Yaneva MP.

Folia Med (Plovdiv). 2017 Dec 20;59(4):396-404. doi: 10.1515/folmed-2017-0054.

PMID:
29341944
6.

Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN.

Valassi E, Franz H, Brue T, Feelders RA, Netea-Maier R, Tsagarakis S, Webb SM, Yaneva M, Reincke M, Droste M, Komerdus I, Maiter D, Kastelan D, Chanson P, Pfeifer M, Strasburger CJ, Tóth M, Chabre O, Tabarin A, Krsek M, Fajardo C, Bolanowski M, Santos A, Wass JAH, Trainer PJ; ERCUSYN Study Group.

Eur J Endocrinol. 2017 May;176(5):613-624. doi: 10.1530/EJE-16-0967.

PMID:
28377460
7.

Autoimmune Phenomena in Patients with Solid Tumors.

Nenova IS, Valcheva MY, Beleva EA, Tumbeva DY, Yaneva MP, Rancheva EL, Grudeva-Popova ZG.

Folia Med (Plovdiv). 2016 Sep 1;58(3):195-199. doi: 10.1515/folmed-2016-0026.

PMID:
27760006
8.

Evaluation of prognostic utility of MIB-1 and p53 expression in pituitary adenomas: correlations with clinical behaviour and follow-up results.

Hadzhiyanev A, Ivanova R, Nachev E, Elenkova A, Yaneva M, Zaharieva S, Marinov M, Surchev J, Ivanova A.

Biotechnol Biotechnol Equip. 2014 May 4;28(3):502-507. Epub 2014 Aug 22.

9.

Treatment outcome results from the Bulgarian Acromegaly Database: adjuvant dopamine agonist therapy is efficient in less than one fifth of non-irradiated patients.

Vandeva S, Elenkova A, Natchev E, Kirilov G, Tcharaktchiev D, Yaneva M, Kalinov K, Marinov M, Hristozov K, Kamenov Z, Orbetzova M, Gerenova J, Tsinlikov I, Zacharieva S.

Exp Clin Endocrinol Diabetes. 2015 Jan;123(1):66-71. doi: 10.1055/s-0034-1389987. Epub 2015 Jan 22.

PMID:
25611123
10.

Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire.

Vandeva S, Yaneva M, Natchev E, Elenkova A, Kalinov K, Zacharieva S.

Endocrine. 2015 Aug;49(3):774-82. doi: 10.1007/s12020-014-0521-6. Epub 2015 Jan 6.

PMID:
25561370
11.

Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.

Nazarian A, Lawlor K, Yi SS, Philip J, Ghosh M, Yaneva M, Villanueva J, Saghatelian A, Assel M, Vickers AJ, Eastham JA, Scher HI, Carver BS, Lilja H, Tempst P.

Mol Cell Proteomics. 2014 Nov;13(11):3082-96. doi: 10.1074/mcp.M114.038836. Epub 2014 Jul 23.

12.

Aminopeptidase activities as prospective urinary biomarkers for bladder cancer.

Taylor JM, Yaneva M, Velasco K, Philip J, Erdjument-Bromage H, Ostrovnaya I, Lilja HG, Bochner BH, Tempst P.

Proteomics Clin Appl. 2014 Jun;8(5-6):317-26. doi: 10.1002/prca.201300118. Epub 2014 Mar 31.

13.

Mortality in Cushing's syndrome: data from 386 patients from a single tertiary referral center.

Yaneva M, Kalinov K, Zacharieva S.

Eur J Endocrinol. 2013 Oct 1;169(5):621-7. doi: 10.1530/EJE-13-0320. Print 2013 Nov.

PMID:
23939921
14.

Multiple myeloma in association with second malignancy.

Grudeva-Popova J, Nenova I, Spasova M, Yaneva M, Beleva E, Ananoshtev N.

J BUON. 2013 Apr-Jun;18(2):448-52.

PMID:
23818360
15.

Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.

Tichomirowa MA, Lee M, Barlier A, Daly AF, Marinoni I, Jaffrain-Rea ML, Naves LA, Rodien P, Rohmer V, Faucz FR, Caron P, Estour B, Lecomte P, Borson-Chazot F, Penfornis A, Yaneva M, Guitelman M, Castermans E, Verhaege C, Wémeau JL, Tabarin A, Fajardo Montañana C, Delemer B, Kerlan V, Sadoul JL, Cortet Rudelli C, Archambeaud F, Zacharieva S, Theodoropoulou M, Brue T, Enjalbert A, Bours V, Pellegata NS, Beckers A.

Endocr Relat Cancer. 2012 May 3;19(3):233-41. doi: 10.1530/ERC-11-0362. Print 2012 Jun.

16.

High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.

Tichomirowa MA, Barlier A, Daly AF, Jaffrain-Rea ML, Ronchi C, Yaneva M, Urban JD, Petrossians P, Elenkova A, Tabarin A, Desailloud R, Maiter D, Schürmeyer T, Cozzi R, Theodoropoulou M, Sievers C, Bernabeu I, Naves LA, Chabre O, Montañana CF, Hana V, Halaby G, Delemer B, Aizpún JI, Sonnet E, Longás AF, Hagelstein MT, Caron P, Stalla GK, Bours V, Zacharieva S, Spada A, Brue T, Beckers A.

Eur J Endocrinol. 2011 Oct;165(4):509-15. doi: 10.1530/EJE-11-0304. Epub 2011 Jul 13.

17.

The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics.

Valassi E, Santos A, Yaneva M, Tóth M, Strasburger CJ, Chanson P, Wass JA, Chabre O, Pfeifer M, Feelders RA, Tsagarakis S, Trainer PJ, Franz H, Zopf K, Zacharieva S, Lamberts SW, Tabarin A, Webb SM; ERCUSYN Study Group.

Eur J Endocrinol. 2011 Sep;165(3):383-92. doi: 10.1530/EJE-11-0272. Epub 2011 Jun 29.

PMID:
21715416
18.

Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes.

Tae S, Karkhanis V, Velasco K, Yaneva M, Erdjument-Bromage H, Tempst P, Sif S.

Nucleic Acids Res. 2011 Jul;39(13):5424-38. doi: 10.1093/nar/gkr170. Epub 2011 Mar 29.

19.

Genetics of Cushing's syndrome.

Yaneva M, Vandeva S, Zacharieva S, Daly AF, Beckers A.

Neuroendocrinology. 2010;92 Suppl 1:6-10. doi: 10.1159/000314215. Epub 2010 Sep 10. Review.

20.

Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.

Daly AF, Tichomirowa MA, Petrossians P, Heliövaara E, Jaffrain-Rea ML, Barlier A, Naves LA, Ebeling T, Karhu A, Raappana A, Cazabat L, De Menis E, Montañana CF, Raverot G, Weil RJ, Sane T, Maiter D, Neggers S, Yaneva M, Tabarin A, Verrua E, Eloranta E, Murat A, Vierimaa O, Salmela PI, Emy P, Toledo RA, Sabaté MI, Villa C, Popelier M, Salvatori R, Jennings J, Longás AF, Labarta Aizpún JI, Georgitsi M, Paschke R, Ronchi C, Valimaki M, Saloranta C, De Herder W, Cozzi R, Guitelman M, Magri F, Lagonigro MS, Halaby G, Corman V, Hagelstein MT, Vanbellinghen JF, Barra GB, Gimenez-Roqueplo AP, Cameron FJ, Borson-Chazot F, Holdaway I, Toledo SP, Stalla GK, Spada A, Zacharieva S, Bertherat J, Brue T, Bours V, Chanson P, Aaltonen LA, Beckers A.

J Clin Endocrinol Metab. 2010 Nov;95(11):E373-83. doi: 10.1210/jc.2009-2556. Epub 2010 Aug 4.

21.

Postoperative chemo-radiotherapy with temodal in patients with glioblastoma multiforme--survival rates and prognostic factors.

Yaneva MP, Semerdjieva ML, Radev LR, Vlaikova MI.

Folia Med (Plovdiv). 2010 Jan-Mar;52(1):26-33.

PMID:
20380284
22.

HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation.

Parmigiani RB, Xu WS, Venta-Perez G, Erdjument-Bromage H, Yaneva M, Tempst P, Marks PA.

Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9633-8. doi: 10.1073/pnas.0803749105. Epub 2008 Jul 7.

23.

Therapy-related acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer: case report with literature review.

Grudeva-Popova J, Yaneva M, Zisov K, Ananoshtev N.

J BUON. 2007 Jan-Mar;12(1):129-32. Review.

PMID:
17436415
24.

Primary solitary eosinophilic granuloma of the brain and postoperative radiotherapy: a clinical case.

Mihova L, Yaneva M, Sopadjieva M, Andreev V, Nejtcheva I.

J BUON. 2007 Jan-Mar;12(1):125-8.

PMID:
17436414
25.
26.

Palliative radiotherapy in patients with multiple myeloma.

Yaneva MP, Goranova-Marinova V, Goranov S.

J BUON. 2006 Jan-Mar;11(1):43-8.

PMID:
17318951
27.

Isolation and mass spectrometry of specific DNA binding proteins.

Yaneva M, Tempst P.

Methods Mol Biol. 2006;338:291-303.

PMID:
16888366
28.

Radionuclide therapy of cancer patients with bone metastases.

Yaneva MP, Semerdjieva M, Radev LR, Ivanova EK, Geiman M, Vlaikova MI, Mihova LS.

Folia Med (Plovdiv). 2005;47(3-4):63-9.

PMID:
16761397
29.

PU.1 and a TTTAAA element in the myeloid defensin-1 promoter create an operational TATA box that can impose cell specificity onto TFIID function.

Yaneva M, Kippenberger S, Wang N, Su Q, McGarvey M, Nazarian A, Lacomis L, Erdjument-Bromage H, Tempst P.

J Immunol. 2006 Jun 1;176(11):6906-17.

30.

Diurnal blood pressure pattern in patients with primary aldosteronism.

Zacharieva S, Orbetzova M, Elenkova A, Stoynev A, Yaneva M, Schigarminova R, Kalinov K, Nachev E.

J Endocrinol Invest. 2006 Jan;29(1):26-31.

PMID:
16553030
31.
32.

Circadian blood pressure profile in patients with Cushing's syndrome before and after treatment.

Zacharieva S, Orbetzova M, Stoynev A, Shigarminova R, Yaneva M, Kalinov K, Nachev E, Elenkova A.

J Endocrinol Invest. 2004 Nov;27(10):924-30.

PMID:
15762039
33.

A prototype antibody microarray platform to monitor changes in protein tyrosine phosphorylation.

Gembitsky DS, Lawlor K, Jacovina A, Yaneva M, Tempst P.

Mol Cell Proteomics. 2004 Nov;3(11):1102-18. Epub 2004 Sep 8.

34.

Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes.

Yaneva M, Mosnier-Pudar H, Dugué MA, Grabar S, Fulla Y, Bertagna X.

J Clin Endocrinol Metab. 2004 Jul;89(7):3345-51.

PMID:
15240613
35.

Delayed-late activation of a myeloid defensin minimal promoter by retinoids and inflammatory mediators.

Wang N, Su Q, Boeckh-Herwig S, Yaneva M, Tempst P.

Leuk Res. 2004 Aug;28(8):879-89.

PMID:
15203286
36.

Affinity capture of specific DNA-binding proteins for mass spectrometric identification.

Yaneva M, Tempst P.

Anal Chem. 2003 Dec 1;75(23):6437-48.

PMID:
14640712
37.

Evaluation of the immunomodulatory activity of Aronia in combination with apple pectin in patients with breast cancer undergoing postoperative radiation therapy.

Yaneva MP, Botushanova AD, Grigorov LA, Kokov JL, Todorova EP, Krachanova MG.

Folia Med (Plovdiv). 2002;44(1-2):22-5.

PMID:
12422622
38.

Influence of age, sex and body weight on renal osteodystrophy in predialysis patients with chronic renal failure.

Kumchev EP, Tzvetkova SB, Enchev ED, Yaneva MP, Dimitrova RH, Botushanova AD, Dimitrakov DJ.

Folia Med (Plovdiv). 2000;42(2):28-33.

PMID:
11217280
39.

Radiotherapy of brain metastases in lung cancer.

Yaneva MP.

Folia Med (Plovdiv). 2000;42(1):34-6.

PMID:
10979174
40.

Assessment of serum osteocalcine level in pre-dialysis patients with chronic renal failure.

Kumchev EP, Stanchev VL, Yaneva MP, Botushanova AD, Dimitrova RH, Dimitrakov DJ.

Folia Med (Plovdiv). 2000;42(1):14-8.

PMID:
10979170
41.
42.
43.

Tying loose ends: roles of Ku and DNA-dependent protein kinase in the repair of double-strand breaks.

Lieber MR, Grawunder U, Wu X, Yaneva M.

Curr Opin Genet Dev. 1997 Feb;7(1):99-104. Review.

PMID:
9024627
44.

Reduced sulphydryl groups are required for DNA binding of Ku protein.

Zhang WW, Yaneva M.

Biochem J. 1993 Aug 1;293 ( Pt 3):769-74.

45.

Factors influencing prognosis of patients with CNS supratentorial astroglial tumors who underwent postoperative radiotherapy.

Yaneva M, Arolski I, Iliev E, Zaprianov Z.

Folia Med (Plovdiv). 1993;35(3-4):49-54.

PMID:
7927055
46.
47.

Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku.

Isern RA, Yaneva M, Weiner E, Parke A, Rothfield N, Dantzker D, Rich S, Arnett FC.

Am J Med. 1992 Sep;93(3):307-12.

PMID:
1524083
48.

Antigenic determinants of the 70-kDa subunit of the Ku autoantigen.

Abu-Elheiga L, Yaneva M.

Clin Immunol Immunopathol. 1992 Aug;64(2):145-52.

PMID:
1379527
49.

On the mechanisms of Ku protein binding to DNA.

Zhang WW, Yaneva M.

Biochem Biophys Res Commun. 1992 Jul 15;186(1):574-9.

PMID:
1632793
50.

Expression of the Ku protein during cell proliferation.

Yaneva M, Jhiang S.

Biochim Biophys Acta. 1991 Oct 8;1090(2):181-7.

PMID:
1932109

Supplemental Content

Loading ...
Support Center